Cytosorbents Corp
CTSO
95 hedge funds and large institutions have $152M invested in Cytosorbents Corp in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 28 reducing their positions, and 14 closing their positions.
14% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 14
2% more funds holding
Funds holding: 93 → 95 (+2)
4% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 28
0.32% less ownership
Funds ownership: 40.71% → 40.39% (-0.32%)
5% less capital inflows, than outflows
Capital inflows: $14.2M | Capital outflows: $14.9M
35% less call options, than puts
Call options by funds: $1.3M | Put options by funds: $2.01M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Avenir Corporation
Alexandria,
Virginia
|
+$1.45M |
| 2 |
Wealth Advisory Solutions
Indiianapolis,
Indiana
|
+$1.33M |
| 3 |
Jacob Asset Management of New York
Hermosa Beach,
California
|
+$1.19M |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
+$1.14M |
| 5 |
Sargent Investment Group
Bethesda,
Maryland
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$7.93M |
| 2 |
Goldman Sachs
New York
|
-$1.92M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.14M |
| 4 |
AIC
AWM Investment Company
New York
|
-$477K |
| 5 |
Neuberger Berman Group
New York
|
-$470K |
CTSO Hedge Fund Activity: Q1 2021 in Review
95 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2021, worth a combined $152M — up 8.2% from $140M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new CTSO positions and 14 closed out — a net gain of 2 holders — while 29 added to existing stakes and 28 trimmed.
The largest buyer was Avenir Corporation, adding an estimated $1.45M. The largest seller was Sectoral Asset Management, cutting an estimated $7.93M.
- 95 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2021, up from 93 in Q4 2020.
- Funds reported $152M of Cytosorbents Corp stock for Q1 2021, up 8.2% quarter-over-quarter.
- 16 funds opened new Cytosorbents Corp positions in Q1 2021 and 14 closed out, a net change of +2 holders.
- The largest Cytosorbents Corp buyer in Q1 2021 was Avenir Corporation, an estimated $1.45M added.
- The largest Cytosorbents Corp seller in Q1 2021 was Sectoral Asset Management, an estimated $7.93M sold.
Based on aggregated 13F filings for Q1 2021.